bioRxiv Science⌕ Search

Biology subjects

Lutz, B. R.

Publications and source records attributed to Lutz, B. R..

3 recordsLinked to original sources

Surfactant-Enhanced Hybridization Capture for Direct Sequence-Specific RNA Extraction from Plasma and Whole Blood

Direct recovery of low-abundance RNA from complex biological samples remains a major challenge for ultrasensitive detection. Sequence-specific hybridization capture enables selective enrichment, but recovery from crude samples is compromised by RNA degradation, protein interference, RNA secondary structure, and target sequence variation. Here, we address these limitations with a sodium dodecyl sulfate (SDS)-based formulation that not only lyses virions and protects RNA, but also directly accelerates hybridization kinetics, substantially reducing the need for thermal denaturation. This enabled direct RNA capture from crude plasma or whole blood with near-quantitative recovery, outperforming a widely used silica-based kit at low input. Without centrifugation or plasma separation, we detected HIV RNA by RT-qPCR at 25 copies/mL directly from whole blood. We further developed a free energy ({Delta}G)-guided algorithm for mutation-robust probe design, achieving >85% mean recovery across HIV-1 subtypes with a single probe. This work opens low-abundance RNA biomarkers in crude biofluids to ultrasensitive detection, addressing a major barrier to early diagnosis.

bioengineering↗

Rapid enzymatic assay for antiretroviral drug monitoring using CRISPR-Cas12a enabled readout

Maintaining efficacy of human immunodeficiency virus (HIV) medications is challenging among children because of dosing difficulties, the limited number of approved drugs, and low rates of medication adherence. Drug level feedback (DLF) can support dose optimization and timely interventions to prevent treatment failure, but current tests are heavily instrumented and centralized. We developed the REverse-transcriptase ACTivity-crispR (REACTR) assay for rapid measurement of HIV drugs based on the extent of DNA synthesis by HIV reverse transcriptase. CRISPR-Cas enzymes bind to synthesized DNA, triggering collateral cleavage of quenched reporters and generating fluorescence. We measured azidothymidine triphosphate (AZT-TP), a key drug in pediatric HIV treatment, and investigated the impact of assay time and DNA template length on REACTRs sensitivity. REACTR selectively measured clinically relevant AZT-TP concentrations in the presence of genomic DNA and peripheral blood mononuclear cell lysate. REACTR has the potential to enable rapid point-of-care HIV DLF to improve pediatric HIV care.

bioengineering↗

Evaluating Specimen Quality and Results from a Community-Wide, Home-Based Respiratory Surveillance Study

IntroductionWhile influenza and other respiratory pathogens cause significant morbidity and mortality, the community-based burden of these infections remains incompletely understood. The development of novel methods to detect respiratory infections is essential for mitigating epidemics and developing pandemic-preparedness infrastructure. MethodsFrom October 2019 to March 2020, we conducted a home-based cross-sectional study in the greater Seattle area, utilizing electronic consent and data collection instruments. Participants received nasal swab collection kits via rapid delivery within 24 hours of self-reporting respiratory symptoms. Samples were returned to the laboratory and were screened for 26 respiratory pathogens and a human marker. Participant data were recorded via online survey at the time of sample collection and one week later. ResultsOf the 4,572 consented participants, 4,359 (95.3%) received a home swab kit, and 3,648 (83.7%) returned a nasal specimen for respiratory pathogen screening. The 3,638 testable samples had a mean RNase P CRT value of 19.0 (SD: 3.4) and 1,232 (33.9%) samples had positive results for one or more pathogens, including 645 (17.7%) influenza-positive specimens. Among the testable samples, the median time between shipment of the home swab kit and completion of laboratory testing was 8 days [IQR: 7.0-14.0]. DiscussionHome-based surveillance using online participant enrollment and specimen self-collection is a feasible method for community-level monitoring of influenza and other respiratory pathogens, which can readily be adapted for use during pandemics.

microbiology↗